NCT00907777 - Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™ | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 23, 2009

Primary Completion Date

October 5, 2009

Study Completion Date

October 5, 2009

Conditions

Infections, StreptococcalStreptococcus Pneumoniae

Interventions

BIOLOGICAL

Pneumococcal conjugate vaccine GSK 1024850A

One dose of vaccine will be injected intramuscularly into the deltoid.

BIOLOGICAL

Pneumococcal conjugate vaccine Prevenar™ (Wyeth Lederle's)

One dose of vaccine will be injected intramuscularly into the deltoid.

Trial Locations (17)

10315

GSK Investigational Site, Berlin

13055

GSK Investigational Site, Berlin

14197

GSK Investigational Site, Berlin

32549

GSK Investigational Site, Bad Oeynhausen

41061

GSK Investigational Site, Mönchengladbach

41236

GSK Investigational Site, Mönchengladbach

42579

GSK Investigational Site, Heiligenhaus

47574

GSK Investigational Site, Goch

47877

GSK Investigational Site, Willich

55131

GSK Investigational Site, Mainz

67227

GSK Investigational Site, Frankenthal

68163

GSK Investigational Site, Mannheim

86720

GSK Investigational Site, Nördlingen

98724

GSK Investigational Site, Neuhaus am Rennweg

99425

GSK Investigational Site, Weimar

04178

GSK Investigational Site, Leipzig

07356

GSK Investigational Site, Bad Lobenstein